A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [<sup>64</sup>Cu]Cu-NOTA-ch14.18/CHO.
Journal Information
Full Title: Theranostics
Abbreviation: Theranostics
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Diagnostic Imaging
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing Interests: The authors have declared that no competing interest exists."
"This work was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation, Germany's Excellence Strategy, EXC2180-390900677). We acknowledge support from the Open Access Publication Fund of the University Tübingen. Dinutuximab beta was provided by EUSA Pharma free of charge. Parts of the graphical abstract and of Figure 1 were created with BioRender."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025